Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment

Chimeric antigen receptor T cells (CAR-T) therapy is a prospective therapeutic strategy for blood cancers tumor, especially leukemia, but it is not effective for solid tumors. Glioblastoma (GBM) is a highly immunosuppressive and deadly malignant tumor with poor responses to immunotherapies. Although...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Guidong, Zhang, Qing, Zhang, Junwen, Liu, Fusheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264285/
https://www.ncbi.nlm.nih.gov/pubmed/34248623
http://dx.doi.org/10.3389/fphar.2021.661606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264285/
https://www.ncbi.nlm.nih.gov/pubmed/34248623
http://dx.doi.org/10.3389/fphar.2021.661606

Ejemplares similares